168 related articles for article (PubMed ID: 15367563)
1. Excitement tempered by long road ahead for dendritic cell vaccines.
Vanchieri C
J Natl Cancer Inst; 2004 Sep; 96(18):1350-1. PubMed ID: 15367563
[No Abstract] [Full Text] [Related]
2. Cancer vaccine strategies get bigger and better.
de Gruijl TD; Curiel DT
Nat Med; 1999 Oct; 5(10):1124-5. PubMed ID: 10502808
[No Abstract] [Full Text] [Related]
3. Therapeutic cancer vaccines.
Morris LF; Ribas A
Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
5. Phase III randomized study of autologous lymphoma-derived idiotype specific vaccination plus GM-CSF in patients with follicular lymphoma in first complete remission.
Clin Adv Hematol Oncol; 2003 Jan; 1(1):67. PubMed ID: 16227966
[No Abstract] [Full Text] [Related]
6. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
7. Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients.
Hansson L; Abdalla AO; Moshfegh A; Choudhury A; Rabbani H; Nilsson B; Osterborg A; Mellstedt H
Clin Cancer Res; 2007 Mar; 13(5):1503-10. PubMed ID: 17332295
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell derived-exosomes: biology and clinical implementations.
Chaput N; Flament C; Viaud S; Taieb J; Roux S; Spatz A; André F; LePecq JB; Boussac M; Garin J; Amigorena S; Théry C; Zitvogel L
J Leukoc Biol; 2006 Sep; 80(3):471-8. PubMed ID: 16809645
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutics in development for prostate cancer.
Harzstark AL; Small EJ
Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
[TBL] [Abstract][Full Text] [Related]
10. Cell Genesys reports long-term survival data in Phase II trial of GVAX.
Expert Rev Anticancer Ther; 2002 Jun; 2(3):245-6. PubMed ID: 12113044
[No Abstract] [Full Text] [Related]
11. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
Timmerman JM
Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
[No Abstract] [Full Text] [Related]
12. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
Dessureault S; Noyes D; Lee D; Dunn M; Janssen W; Cantor A; Sotomayor E; Messina J; Antonia SJ
Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell/tumour fusions vaccine.
Avigan D
Dev Biol (Basel); 2004; 116():161-8; discussion 179-86. PubMed ID: 15603191
[No Abstract] [Full Text] [Related]
15. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell immunotherapy for the treatment of neoplastic disease.
Decker WK; Xing D; Shpall EJ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
18. Highly successful therapeutic vaccinations combining dendritic cells and tumor cells secreting granulocyte macrophage colony-stimulating factor.
Driessens G; Hamdane M; Cool V; Velu T; Bruyns C
Cancer Res; 2004 Nov; 64(22):8435-42. PubMed ID: 15548715
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with dendritic cells for cancer.
Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitive effects of gastric cancer cell-dendritic cell fusion vaccine on tumor cell proliferation cycle].
Zhang K; Yu PW; Gao PF; Rao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):345-8. PubMed ID: 16886121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]